TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche

• Published in: The Journal of clinical investigation Vol. 132; no. 11
• Main Authors: Yao, Juo-Chin, Oetjen, Karolyn A, Wang, Tianjiao, Xu, Haoliang, Abou-Ezzi, Grazia, Krambs, Joseph R, Uttarwar, Salil, Duncavage, Eric J, Link, Daniel C
• Format: Journal Article
• Language: English
• Published: United States American Society for Clinical Investigation 01.06.2022
• Subjects: Bone Marrow - metabolism; Hematology; Humans; Myeloproliferative Disorders - genetics; Myeloproliferative Disorders - metabolism; Neoplasms - metabolism; Oncology; Primary Myelofibrosis - genetics; Primary Myelofibrosis - metabolism; Transforming Growth Factor beta - genetics; Transforming Growth Factor beta - metabolism; Tumor Microenvironment; Bone marrow; Oncology; Hematology; Leukemias; Fibrosis
• ISSN: 1558-8238; 0021-9738; 1558-8238
• DOI: 10.1172/JCI154092

Myeloproliferative neoplasms (MPNs) are associated with significant alterations in the bone marrow microenvironment that include decreased expression of key niche factors and myelofibrosis. Here, we explored the contribution of TGF-β to these alterations by abrogating TGF-β signaling in bone marrow mesenchymal stromal cells. Loss of TGF-β signaling in Osx-Cre-targeted MSCs prevented the development of myelofibrosis in both MPLW515L and Jak2V617F models of MPNs. In contrast, despite the absence of myelofibrosis, loss of TGF-β signaling in mesenchymal stromal cells did not rescue the defective hematopoietic niche induced by MPLW515L, as evidenced by decreased bone marrow cellularity, hematopoietic stem/progenitor cell number, and Cxcl12 and Kitlg expression, and the presence of splenic extramedullary hematopoiesis. Induction of myelofibrosis by MPLW515L was intact in Osx-Cre Smad4fl/fl recipients, demonstrating that SMAD4-independent TGF-β signaling mediates the myelofibrosis phenotype. Indeed, treatment with a c-Jun N-terminal kinase (JNK) inhibitor prevented the development of myelofibrosis induced by MPLW515L. Together, these data show that JNK-dependent TGF-β signaling in mesenchymal stromal cells is responsible for the development of myelofibrosis but not hematopoietic niche disruption in MPNs, suggesting that the signals that regulate niche gene expression in bone marrow mesenchymal stromal cells are distinct from those that induce a fibrogenic program.